M&As this week: BTC Network, Pfizer INC

4th August 2016 (Last Updated August 4th, 2016 18:30)

BTC Network has acquired Novex Clinical Research LLC, to strengthen its expertise and commitment in therapeutic areas such as psychiatry, neurology, pain and internal medicine.

BTC Network has acquired Novex Clinical Research LLC, to strengthen its expertise and commitment in therapeutic areas such as psychiatry, neurology, pain and internal medicine.

Following the transaction, Novex Clinical Research will be known as BTC of New Bedford, Massachusetts, and will be the first clinical research site to operate under BTC Network.

"Pfizer INC. has completed the acquisition of Bamboo Therapeutics, a clinical-stage gene therapy company."

Pfizer INC. has completed the acquisition of Bamboo Therapeutics, a clinical-stage gene therapy company.

Pfizer purchased 22% of Bamboo’s fully diluted equity for $43m earlier this year, while acquiring the remaining equity by paying $150m upfront.

Bamboo’s selling shareholders will additionally receive potential milestone payments of up to $495m, therefore bringing the total value of the acquisition to $688m.

Pfizer aims to strengthen its presence in the treatment of rare diseases through the acquisition.


Image : Pfizer INC. has completed the acquisition of Bamboo Therapeutics. Photo: Courtesy of Neruru.